BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//PlainTrial//Saved Trials Calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:PlainTrial saved trials
X-WR-CALDESC:Estimated completion dates for the clinical trials you saved o
 n PlainTrial.
BEGIN:VEVENT
UID:plaintrial-NCT00045396-start@plaintrial.com
DTSTAMP:20260929T071615Z
DTSTART;VALUE=DATE:200206
SUMMARY:A Phase II Study Of The Farnesyltransferase Inhibitor ZANESTRA (R11
 5777\, NSC #702818\, IND #58\,359) In Complete Remission Following Inducti
 on And/Or Consolidation Chemotherapy In Adults With Poor-Risk Acute Myelog
 enous Leukemia (AML) And High-Risk Myelodysplasia (MDS) — estimated star
 t (no completion date on record) date
DESCRIPTION:Completed. Saved on your PlainTrial shortlist. Full trial recor
 d: https://plaintrial.com/trial/NCT00045396
URL:https://plaintrial.com/trial/NCT00045396
END:VEVENT
END:VCALENDAR